Stanley Druckenmiller sold most of his Teva and TSM shares, bought $301M in financial ETF, signaling shift to financial sector bets.

In Q4 2025, billionaire investor Stanley Druckenmiller reduced his stakes in Teva Pharmaceutical by 65% and Taiwan Semiconductor by 29%, likely due to strong gains since late 2024. He simultaneously invested $301 million in the State Street Financial Select Sector SPDR ETF, making it his fund’s second-largest holding. The shift suggests a strategic move toward financial sector exposure, potentially betting on future interest rate stability or increases despite the Fed’s ongoing rate-easing cycle since September 2024.